Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Gastrointestinal 2Thoracic 1Breast 1

Conditions

Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 30Nivolumab 10Cyclophosphamide 9fludarabine 7atezolizumab 7aldesleukin 5Paclitaxel 5Magnetic Resonance Spectroscopy 5Ipilimumab 5Carboplatin 5Biopsy 5cemiplimab 4Trastuzumab 4Interleukin-2 4Docetaxel 4Cisplatin 4spartalizumab 3durvalumab 3Specimen Handling 3Polymerase Chain Reaction 3Gene Expression Profiling 3Fulvestrant 3Fluorouracil 3tisotumab vedotin 2tislelizumab 2palbociclib 2fludarabine phosphate 2entinostat 2avelumab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Diphenhydramine × Head & Neck × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

NCT04237090 2020-10-12

PREMED-F1

Ciusss de L'Est de l'Île de Montréal

Phase 3 Completed
27 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡